Small Cap Feast
Small Cap Feast – 19 November 2019
Dish of the Day:
No Joiners Today
No Joiners Today
Off the Menu:
No Leavers Today
No Leavers Today
What’s Cooking in the IPO Kitchen?
The Pebble Group, a provider of products, services and technology to the global promotional products industry, announces its intention to seek admission of its shares to trading on the AIM market of the London Stock Exchange, which is expected to take place in early December 2019.The Group delivered revenue of £99.8m in the year ended 31 December 2018.No mention of bottom line and a suggestion that funds raised would provide an exit to private equity shareholders and the repayment of debt. Offer TBA.
Longboat Energy raising £10m. Expected admission November 2019. The company has been established by the former management team of Faroe Petroleum to create a new full-cycle North Sea oil and gas company .The strategy to achieve this will initially be through the acquisition of assets where the management team can add value through subsurface and operational improvements, follow-up deal opportunities and near-field exploration; and by value creation through the drill bit.
Sapo PLC – an investment vehicle under the NEX Exchange Rules, seeks to invest in the developing market for rural broadband in the United Kingdom. Due 2 Dec
Main Mkt Standard
Taseko Mines – North American focused copper producer and developer, seeking a London Listing. No capital raise. Due 22 Dec
SDIC Power – “potential intention to float”. Proposed GDR listing. Leading power generation company in China, with a diversified portfolio of projects across hydropower, coal-fired power, wind power and solar power. Offer TBA
Oriole Resources (ORR.L) 0.42p £2.95m
Update on its 26.1 per cent (‘%’) interest in the private East African explorer Thani Stratex Resources Limited (‘TSR’) that has assets in Djibouti and Egypt.
TSR has reached agreement with Onyx EX B.V. (‘Onyx’) in respect of their joint venture company, Thani Stratex Djibouti Limited (‘TSD’), for the funding of an exploration programme in TSD (the ‘Funding’). This funding is being underwritten by African Minerals Exploration & Development Fund III and will allow an accelerated exploration programme in Djibouti over the next three years. The Funding will be available in tranches and is subject to achieving pre-defined performance milestones.
The first US$2.5m tranche of the Funding will be used to undertake an initial 6,500 metres of drilling
Cora Gold (CORA.L) 5.375p £6.97m
Commencement of Drilling at Sanankoro.
- 5,000m drilling programme commenced with completion during Q4 2019
- Programme designed to:
o further investigate the sulphide and deep oxide potential below known mineralisation at key prospects; and
o extend existing and potential new shallow oxide targets
- Exploration team re-mobilised to Sanankoro over the last month following the wet season
- Drilling to date has covered less than c.25% of the 1-2Moz exploration target area
ECSC (ECSC.L) 92.5p £8.4m
Trading update from the provider of cyber security services.
Continued strong growth in Consulting sales since interim period end of June 2019
- Record levels of Consulting, Managed Services and Incident Response revenue in Q3, with organic growth circa 25%
- Record levels of Consulting bookings in Q4 to-date
- Cash of £0.45m as at 31 October 2019 (£0.19m at 30 June 2019), with an unused banking facility of £0.5m
- Continued recruitment of sales partners, with 87 partners to-date generating over 100 new sales opportunities
- 2019 results likely to be broadly in line with current market expectations
Scapa (SCPA.L) 232.25p £360.6m
H1 19 results. Revenue grew 14.3% to £160.8m (2018: £140.7m); 10.4% on a constant currency basis. Trading profit fell 17.0% to £14.2m (2018: £17.1m); 20.7% on a constant currency basis, representing a trading profit margin reduction to 8.8% (2018: 12.2%); reported operating profit fell to £0.1m (2018: £10.5m); reflecting the impact of the loss of the ConvaTec contract.
“Scapa has again delivered a solid first half performance with growth in revenue, despite the significant impact of the loss of the ConvaTec contract, resulting in reduced trading profit and margins. There are further significant opportunities for both business units to improve sales and margin performance through rigorous execution of the strategy, in the short and longer term. The Board remains confident of delivering its full year expectations and in the Company’s ability to drive shareholder value.”
GAN (GAN) 144p £122.5m
Update following the publication on November 18, 2019, by the Pennsylvania Gaming Control Board (“PGCB”) of Internet gaming and Internet sports betting financial information for the calendar month of October 2019 in Pennsylvania.
Highlights from the PGCB include:
- Internet Gaming Win was $4.9m in October, reflecting an increase of 19.5% from the prior sequential month. This compares to:
– $4.1m for the month of September;
– $3.4m for the month of August; and
– $0.8m for the month of July.
Uniphar (UPR.L) 1.225p £334m
Uniphar plc marks its entry into Nordic and Baltic markets with the acquisition of leading international medtech service provider EPS Group and also announces the acquisition of Irish Medtech service provider M3 Medical. On a proforma basis for the full year ending 31 December 2019, these acquisitions in aggregate are expected to deliver revenue of an estimated €22m. Both the EPS Group and M3 Medical will be integrated into the Commercial & Clinical Medtech division of Uniphar. The total potential consideration payable to the vendors of the EPS Group and M3 Medical is €40m over four years, the deferred consideration to be linked to EBITDA performance over the four years.
ITM Power (ITM.L) 78.8p £371.2m
The energy storage and clean fuel company, and Iwatani Corporation of America (“ICA”), a wholly owned subsidiary of Iwatani Corporation (8088: Tokyo Stock Exchange) are pleased to announce that the two companies have signed a collaboration agreement for the deployment of multi MW electrolyser based hydrogen energy systems in North America.
Particular areas of interest lie in the California hydrogen refuelling station market and large-scale liquid and gaseous renewable hydrogen production for domestic and export markets.
Equals (EQLS.L) 84.8p £151m
Further acquisition aligned to its publicly stated expansion strategy. The Group has today acquired the entire issued ordinary share capital of Casco Financial Services Limited (“Casco”), a UK based payment services provider (the “Acquistion“). The initial consideration for the Acquisition is £1.725m with a potential additional consideration of £2.0m, depending on future performance. For the last 12 calendar months to 31 October 2019, Casco generated unaudited revenue of £3.3m, EBITDA of £0.3m and profit before tax of £0.2m. Post-acquisition, Equals expects to extract cost synergies of £0.4m per annum. As at 31 October 2019, Casco had net assets of approximately £0.3m.
Kape Technologies (KAPE.L) 105p £151m
The consumer security software business, announces the proposed acquisition of LTMI Holdings (“LTMI”), for a total consideration of c. US$95.51m and an enterprise value of c. US$127.6m . holding company for Private Internet Access (“PIA”), a leading US-based digital privacy company with a strong position in data privacy services and over 1 million paying customers .
Enlarged group is expected to generate consolidated proforma 2020 revenues of between US$120-123m and Adjusted EBITDA of between US$35-38m.
Arc Minerals (ARCM.L) 2.65p £19.6m
Binding term sheet setting out an option to sell its interest in the Šturec gold project or the in Slovakia to MetalsTech Limited An Australian listed mineral exploration company for a gross consideration of up to US$8m. Option Fee $30k
0203 764 2344
*A corporate client of Hybridan LLP
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email firstname.lastname@example.org with “unsubscribe me”.